FDA Drug information
R
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- Rabeprazole sodium
- Rabeprazole Sodium DR
- RABERPRAZOLE SODIUM D/R
- Radiogardase
- Raloxifene Hydrochloride
- Ramelteon
- Ramipril
- Ranitidine
- Ranitidine Hydrochloride
- Ranolazine
- Rapamune
- Rasagiline
- Rasagiline Mesylate
- Rasuvo
- Raxibacumab
- RAYOS
- Readi-Cat 2
- Readi-Cat 2 Banana Smoothie
- Readi-Cat 2 Berry Smoothie
- Readi-Cat 2 Creamy Vanilla Smoothie
- Readi-Cat 2 Mochaccino Smoothie
- REBIF
- REBIF REBIDOSE
- Reblozyl
- RECARBRIO
- Reclast
- Recorlev
- Rectiv
- Regadenoson
- Regonol
- REGRANEX
- RELENZA
- RELEUKO
- RELEXXII
- Relpax
- Reltone 200 mg
- Reltone 400 mg
- RELYVRIO
- REMICADE
- Remifentanil Hydrochloride
- Remodulin
- Renacidin
- Renflexis
- Renova
- Renvela
- Repaglinide
- REPATHA
- RESTASIS
- Restasis MultiDose
- RESTORIL
- RETACRIT
- RETEVMO
- Retin-A
- Retin-A MICRO
- Retisert
- RETROVIR
- Revatio
- Reveos Select CPD/AS-5 Red Cell Preservative For Collection Of Blood
- Revlimid
- Revonto
- Rexulti
- REZIPRES
- Rezvoglar KwikPen
- REZZAYO
- Rhofade
- Rhopressa
- Riabni
- Ribavirin
- Rifabutin
- Rifadin IV
- Rifadin IV NOVAPLUS
- Rifampin
- Rilutek
- Riluzole
- RINGERS
- Ringers Irrigation
- Rinvoq
- Riomet
- Risedronate Sodium
- RISPERDAL
- RISPERDAL M-TAB
- Risperidone
- RISVAN
- Ritalin
- Ritalin LA
- Ritonavir
- Ritonavir film coated
- Rituxan
- Rituxan Hycela
- Rivastigmine
- RIVASTIGMINE TARTRATE
- Rivastigmine Transdermal System
- Rizatriptan
- Rizatriptan Benzoate
- ROBAXIN
- Robinul
- Robinul Forte
- Rocklatan
- Rocuronium
- Rocuronium bromide
- Roflumilast
- Romidepsin
- Ropinirole
- Ropinirole hydrochloride
- Ropivacaine hydrochloride
- Rosuvastatin
- Rosuvastatin Calcium
- Rowasa
- Roweepra
- Roxicodone
- RoxyBond
- Rozerem
- Rubraca
- RUBY-FILL
- Ryaltris
- RYANODEX dantrolene sodium
- RYBELSUS
- RYDAPT
- Rylaze
- RYTARY
- RYTHMOL SR
- RYZNEUTA
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.